BACITRACIN-NEOMYCIN-POLYMYXIN Drug Patent Profile
✉ Email this page to a colleague
When do Bacitracin-neomycin-polymyxin patents expire, and when can generic versions of Bacitracin-neomycin-polymyxin launch?
Bacitracin-neomycin-polymyxin is a drug marketed by Pharmaderm, Altana, and Padagis Us. and is included in three NDAs.
The generic ingredient in BACITRACIN-NEOMYCIN-POLYMYXIN is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACITRACIN-NEOMYCIN-POLYMYXIN?
- What are the global sales for BACITRACIN-NEOMYCIN-POLYMYXIN?
- What is Average Wholesale Price for BACITRACIN-NEOMYCIN-POLYMYXIN?
Summary for BACITRACIN-NEOMYCIN-POLYMYXIN
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
DailyMed Link: | BACITRACIN-NEOMYCIN-POLYMYXIN at DailyMed |